Wall Street’s ‘fear gauge’ books biggest daily jump in a month as health bill is delayed

A popular gauge of volatility, or fear, on Wall Street Tuesday surged by the most since mid-May as the stock market ended firmly lower in afternoon trade. The CBOE Volatility Index was up more than 13% at 11.21, its largest daily jump since May 17, when it climbed more than 46%, according to FactSet data. The so-called VIX, otherwise known as the fear gauge, measures options bets on the S&P 500 index 30 days in the future and is used by traders to wager on sharp swings in the market. The indicator is often used as a measure of how investors are positioned for sudden market selloffs, because stocks tend to fall faster than they rise. Wall Street views passage of the health-care legislation as a proxy for President Donald Trump’s ability to get through a raft of other business-friendly laws, including tax cuts, deregulation and infrastructure spending. That trio has helped to push markets to recent repeated records, but doubts around the president’s ability to pass his agenda has often led to downdrafts in assets perceived as risky, like stocks. Tuesday’s action saw technology stocks, as measured by the Nasdaq Composite Index , closed down 1.6%, taking the brunt of the selling pressure. A tech-specific exchange-traded fund, the Technology Select Sector SPDR ETF , also was down sharply. The Dow Jones Industrial Average finished off 0.5%, while the S&P 500 closed down 0.8%. The Health Care Select Sector SPDR ETF wrapped up the session down 0.9%, while the biotech-oriented iShares Nasdaq Biotechnology ETF finished 2.76% lower, posting its worst daily decline since a 2.77% drop March 21.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Tech rout puts Nasdaq on pace for 1st monthly loss in 2017, as stock market ends lower

Carnage in technology shares put the Nasdaq Composite on track for its first monthly decline in 2017, as a delay in a key health-care bill in the Senate casts doubt on President Donald Trump’s pro-growth agenda. GOP senators postponed a vote on the controversial bill to overhaul so-called Obamacare until after the July 4 recess. The Nasdaq Composite Index closed off 1.6%, marking its worst daily decline since June 9th, when tech suffered a 1.8% collapse. The S&P 500 ended off 0.8% at 2,419, while the Dow Jones Industrial Average finished 0.5% lower at 21,310. Selling in health-care related sectors, particularly in biotech, which would presumably be the most affected by the legislation, was the most pronounced. The exchange-traded iShares Nasdaq Biotechnology ETF ended 2.76%, representing its steepest one-day drop since a 2.77% drop March 21. Health-care related ETF, the Health Care Select Sector SPDR ETF , closed down 0.9%. Meanwhile, the tech-focused Technology Select Sector SPDR ETF wrapped up off 1.6%, its worst daily drop since June 9. Meanwhile, financial stocks were one of the few bright spots on the day, with a 0.5% rise for the bank-focused Financial Select Sector SPDR ETF , led by a 1.8% rise in Charles Schwab Corp. and Regions Financial Corp. .

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

National Enquirer owner David Pecker is interested in a bid for Time Inc.

National Enquirer owner David Pecker has been mulling over a potential bid to buy out struggling magazine and media publisher Time Inc. , according to a feature in the July 3 edition of The New Yorker. The nugget is buried in an in-depth profile on Pecker’s friendship with, and his tabloid’s support of President Donald Trump. Back in April the Sport’s Illustrated, People and Time publisher was entertaining bids, but ultimately decided not to put itself up for sale. However, as the New Yorker story notes, even if Time were on the market, Pecker couldn’t buy the company outright himself. He would need a deep-pocketed partner. Time, like many of its peers, has struggled to contend with a declining print business, recently cutting 300 jobs in order to facilitate a shift to digital. Shares of Time have declined more than 23% in the year to date, while the S&P 500 index have gained more than 8%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Biggest jump in a month for Wall Street’s ‘fear gauge’ as health bill is delayed

A popular gauge of volatility, or fear, on Wall Street Tuesday surged by the most since mid-May as the stock market turned firmly lower in afternoon trade. The CBOE Volatility Index was up 12% at 11.07 and on pace to mark its largest daily jump since May 17, when it climbed more than 46%, according to FactSet data. The so-called VIX, otherwise known as the fear gauge, measures options bets on the S&P 500 index 30 days in the future and is used by traders to wager on sharp swings in the market. The indicator is often used as a measure of how investors are positioned for sudden market selloffs, because stocks tend to fall faster than they rise. Wall Street views passage of the health-care legislation as a proxy for President Donald Trump’s ability to get through a raft of other business-friendly laws, including tax cuts, deregulation and infrastructure spending. That trio has helped to push markets to recent repeated records, but doubts around the president’s ability to pass his agenda has often led to downdrafts in assets perceived as risky, like stocks. Tuesday’s action saw technology stocks, as measured by the Nasdaq Composite Index , down 1.3%, take the brunt of the selling pressure. A tech-specific exchange-traded fund, the Technology Select Sector SPDR ETF , also was down sharply. The Dow Jones Industrial Average was trading 0.3% lower, while the S&P 500 was off 0.5%. The Health Care Select Sector SPDR ETF was down 0.5% in recent trade.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Oil tallies fourth-straight session rise as analysts forecast a weekly decline in U.S. crude supplies

Oil prices climbed Tuesday for a fourth session in a row, as analyst forecasts pointed to a weekly drop in U.S. crude supplies. The market predicts that output disruptions caused by Tropical Storm Cindy will contribute an inventory decline for last week. August West Texas Intermediate crude added 86 cents, or 2%, to settle at $44.24 a barrel on the New York Mercantile Exchange.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

U.S. stocks fall to session lows; Nasdaq down more than 1%

U.S. stocks fell on Tuesday, with major indexes nearing their lows of the session and the Nasdaq dropping more than 1%. The Dow Jones Industrial Average slid 47 points, or 0.2%, to 21,361. The S&P 500 was down 11 points to 2,428, a decline of 0.5%. The Nasdaq Composite Index sank 1.2% to 6,175, a decline of 73 points. The outsize drop in the Nasdaq was due to weakness in the technology sector, which led the day’s decline by falling 1.5%. Among the biggest drags in the index, Google parent Alphabet Inc. fell 2% while Facebook lost 1.5%. Separately, Amazon.com Inc. lost 1.2%. Also impacting markets were Republicans in the U.S. Senate, who opted to postpone a vote on a controversial bill to replace Obamacare with a conservative alternative. Some investors have viewed health-care reform, a major legislative priority for President Donald Trump, as a symbol of how easily Trump can get his economic initiatives through Congress. As markets spiked following his election, in large part on expectations for his agenda, many analysts view getting his bills passed as necessary for justifying current valuations.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Senate Republicans delay vote on health bill to replace Obamacare

WASHINGTON (MarketWatch)- Republican Senate leaders postponed until after the July 4 holiday a vote on a controversial bill to replace Obamacare with a conservative alternative. The decision Tuesday to put off a vote this week reflects the difficulty Republicans face in lining up enough votes to approve the bill. Right now they lack enough support given their razor-thin majority in the Senate.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

SEC charges three with insider trading in cancer drug company

The Securities and Exchange Commission brought insider trading charges on Tuesday against two former senior employees and the spouse of a former employee of Ariad Pharmaceuticals, Inc.[s:Aria] for allegedly trading in advance of announcements about U.S. Food and Drug Administration decisions that impacted the sales and marketing of the company’s main cancer drug. According to the SEC’s complaint, Harold Altvater, whose wife was an Ariad employee, allegedly made multiple illegal trades in Ariad stock on the basis of non-public information he learned from her. Maureen Curran, a former Ariad executive, sold Ariad stock in December 2012, after she had attended meetings with the FDA and had learned material nonpublic information regarding a forthcoming FDA decision. Susan Dubuc, another former executive, allegedly tipped relatives in October 2013, one day before Ariad publicly announced a pause in all clinical trials for its FDA-approved drug. Without admitting or denying the SEC’s allegations, Curran and Dubuc have settled with the SEC subject to court approval. Curran agreed to pay $20,248 in disgorgement, penalties and interest. Dubuc agreed to pay $6087. The charges against Altvater are still pending.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Gold prices settle higher as U.S. dollar drops, equities weaken

Gold prices settled higher Tuesday, recouping a small part of the hefty losses from a day earlier. Investment demand for the metal got a boost from a sharp decline in the dollar as well as a broad fall in U.S. equities. But prices pared much of their earlier gains as Federal Reserve Chairwoman Janet Yellen started speaking about global economic issues at an event in London in the minutes ahead of gold’s price settlement. August gold rose 50 cents, or less than 0.05%, to settle at $1,246.90 an ounce.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Facebook reaches two billion users

Facebook Inc. announced Tuesday that the company has reached two billion people on its main platform. Facebook had 1.94 billion monthly users in March as well as 1.2 billion on WhatsApp as of February and 1.2 billion on its Messenger app as of April. Instagram had 700 million monthly users as of April. Facebook’s user numbers dwarf social competitor Twitter Inc. , which most recently reported 328 million monthly active users for the first quarter of 2017. Shares of Facebook were down 1% Tuesday. Facebook shares have gained 8% in the last three months, compared to the S&P 500’s gain of 4%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News